This study suggests that activation of CCR7 with CCL21 can significantly promote proliferation of NSCLC cells in a time-dependent manner involving cyclin A, cyclin B1, and CDK1, possibly via the ERK, but not the Akt, pathway. The gene discussed is CCNA2; the disease is non-small cell lung carcinoma.